Back
Genmab A/S Stock Predictions
Sponsored
GMAB
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
27
GMAB
Genmab A/S
Last Price:
29.72
Seasonality Move:
7.02%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Genmab A/S Stock Forecast
- Over the next 52 weeks, Genmab A/S has on average historically risen by 63.6% based on the past 10 years of stock performance.
- Genmab A/S has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Genmab A/S Stock Undervalued?
The current Genmab A/S [GMAB] share price is $27.70. The Score for GMAB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal. - GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Genmab A/S Stock Go Up Next Year?
- Over the next 52 weeks, Genmab A/S has on average historically risen by 63.6% based on the past 10 years of stock performance.
Genmab A/S Stock Rating
Sell
27
Genmab A/S (GMAB)
is a Sell
Is Genmab A/S overpriced?
- Genmab A/S has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Genmab A/S Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com
52-Week Data
52-Week High:
42.72
52-Week Low:
26.32
Prediction Charts
Market Cap:
18.07B
Price in USD:
27.70
Volume:
633.89K
Beta:
0.82
Technical Analysis
SMA50:
29.36
SMA100:
29.59
SMA200:
32.20
52-Wk Change:
-32.26%
Stock Predictions
-
Is Genmab A/S stock public?
Yes, Genmab A/S is a publicly traded company. -
What is the Genmab A/S stock quote today?
The Genmab A/S stock price is 27.70 USD today. -
How to buy Genmab A/S stock online?
You can buy Genmab A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-15 | 29.36 | 29.50 | 29.67 | 29.26 |
Apr-16 | 29.06 | 29.44 | 29.61 | 28.77 |
Apr-17 | 28.78 | 28.50 | 28.84 | 28.44 |
Apr-18 | 28.46 | 28.32 | 28.62 | 28.29 |
Apr-19 | 28.47 | 28.70 | 28.81 | 28.45 |
Apr-22 | 28.85 | 28.96 | 29.21 | 28.72 |
Apr-23 | 28.76 | 28.54 | 29.04 | 28.54 |
Apr-24 | 28.75 | 28.47 | 28.76 | 28.09 |
Apr-25 | 27.66 | 27.46 | 27.80 | 27.43 |
Apr-26 | 28.09 | 28.15 | 28.18 | 27.91 |
Apr-29 | 28.01 | 28.57 | 28.65 | 28.01 |
Apr-30 | 27.94 | 27.68 | 28.40 | 27.66 |
May-1 | 28.05 | 28.72 | 29.00 | 27.97 |
May-2 | 28.27 | 27.70 | 28.27 | 27.42 |
Genmab A/S Earnings
Genmab A/S Earnings Report: Per Share Genmab A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.
Genmab A/S Forecast Revenue Growth
Genmab A/S Stock Analysis: Historical quarterly revenues per share for Genmab A/S and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.02 per share, and an increase next year of $0.47 per share.
* Genmab A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.